For generations, medicine has measured the body's vulnerability to heart disease through the crude lens of weight and height, missing the quieter crisis unfolding within aging muscle. Researchers at Queen Mary, University of London have now trained an artificial intelligence to read chest scans already taken by the millions, detecting the simultaneous loss of muscle and gain of fat that traditional metrics cannot see. Their study of more than 55,000 patients found that those most affected carry a 37 percent greater risk of death and a 31 percent higher chance of heart failure — a finding that
The Star
· Jul 21, 2026
· health
· 2 min de leitura
High
Apuração: Verificado
AI chest muscle scans identify heart failure and death risk in older patients
◉
Technology
9430 artigos relacionados
Google Launches Gemini Enterprise for Legal Services
Google News · 100% correspondência
Apple Sues OpenAI for Trade Secret Theft by Former Employees
CNET · 99% correspondência
Apple sues OpenAI for allegedly stealing trade secrets through former …
The Straits Times · 99% correspondência
Apple sues OpenAI for trade secret theft in landmark case against form…
Times of India · 99% correspondência
Judge allows Musk's X and xAI antitrust lawsuit against Apple and Open…
Times of India · 99% correspondência
Cobertura Relacionada
euronews.com · Sep 04
AI identifies migraine as spectrum disorder with distinct biological subtypes
Norwegian researchers used AI and genetic data from 43,000 people to identify migraine as a spectrum disorder with disti…
AdExchanger · Sep 04 TikTok Expands Comments With Multimedia; Meta's AI Agent Fails Safety TestsTikTok introduces multimedia comments with voice, polls and videos; Meta's AI personal agent Hatch encountered safety fa…
Mashable · Sep 04 Hurdle hints and answers for September 4, 2026Mashable provides hints and answers for the September 4, 2026 Hurdle word puzzle game, featuring five rounds with progre…
eftm.com · Sep 04 DJI Osmo 360 II Brings 8K 60fps Panoramic Video and Swappable LensesDJI unveiled the Osmo 360 II at IFA, featuring dual 1-inch square sensors, 8K 60fps panoramic video capture, and innovat…
Viés e Enquadramento
⚖
Article presents AI medical research findings with straightforward reporting; minimal bias detected, though framing emphasizes clinical promise without discussing limitations or alternative approaches.
Bias Direction
center
Confidence
MED
Solution-oriented framing that emphasizes the potential benefits of AI technology in medical diagnosis. The article frames sarcopenic obesity as an underdiagnosed problem that AI can solve, positioning the technology as progressive and helpful.
crucial sign of health deterioration
key risk factors for heart disease
most central health problems of our time
take action to protect their health
Limitations of the AI tool or potential false positives/negatives
Cost-effectiveness or accessibility concerns for implementing this technology
Perspectives from patients or clinicians on practical implementation challenges
Comparison with existing diagnostic methods beyond BMI
Potential risks of over-diagnosis or medicalization of aging
Independent verification or criticism from other research institutions
Impacto Geopolítico
🌎
Medical AI advancement in cardiac risk detection has no direct geopolitical implications; primarily a healthcare technology development.
Escalation Risk
low
Confidence
HIGH
Lente Econômica
📈
AI-powered chest muscle scanning technology identifies sarcopenic obesity, enabling early detection of patients with 37% higher mortality risk and 31% increased heart failure risk, potentially reducing healthcare costs through preventive interventions.
Market Signal
bullish
Confidence
HIGH
Healthcare and Medical Devices
Diagnostic Imaging Technology
Pharmaceutical and Preventive Medicine
Elderly Care and Long-term Care Services
Health Insurance and Risk Management
Older patients gain access to more accurate health risk assessment, enabling early intervention and potentially reducing catastrophic health events. May increase demand for preventive healthcare services, fitness programs, and nutritional interventions, though diagnostic costs could initially burden patients without comprehensive insurance coverage.
Healthcare systems may adopt this AI tool as standard screening for elderly populations, potentially influencing insurance reimbursement policies and preventive care guidelines. Regulatory bodies may need to establish standards for AI diagnostic accuracy. Public health initiatives could prioritize sarcopenia screening and muscle-loss prevention programs, particularly in aging societies.